Nagle, A., Biggart, A., Be, C., Srinivas, H., Hein, A., Caridha, D., . . . Molteni, V. (2020). Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases. J Med Chem.

Nagle, Advait, et al. "Discovery and Characterization of Clinical Candidate LXE408 As a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases." J Med Chem 2020.

Nagle, Advait, et al. "Discovery and Characterization of Clinical Candidate LXE408 As a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases." J Med Chem 2020.